J. Christopher States | Carcinogenesis | Best Researcher Award

Dr. J. Christopher States | Carcinogenesis | Best Researcher Award

Professor at University of Louisville, United States
Summary:

Dr. J. Christopher States is an esteemed academic with over four decades of experience in molecular biology and toxicology. Currently a Professor of Pharmacology and Toxicology at the University of Louisville, he has held prominent research and administrative positions, including Vice Chair for Research. His academic contributions have earned him numerous honors, including the 2017 Career Achievement Award from the Society of Toxicology’s Metals Specialty Section and the 2020 University of Louisville Distinguished Faculty Award for research excellence. A recognized leader in toxicology, Dr. States has served on NIH study sections, contributed to the U.S. Environmental Protection Agency’s advisory panels, and is a Distinguished University Scholar. He has been a dedicated mentor to students and researchers, with a legacy of impactful research in cancer biology and environmental health.

Professional Profile:

👩‍🎓Education:

  • B.S. in Biochemistry, State University of New York at Buffalo, Buffalo, NY, 1974
  • Ph.D. in Molecular Biology and Pathology, Albany Medical College, Union University, Albany, NY, 1980

🏢 Professional Experience:

Dr. J. Christopher States is a distinguished professor specializing in molecular biology, toxicology, and pharmacology. After earning his Ph.D., Dr. States completed a postdoctoral fellowship at the University of Calgary, Canada, in Medical Biochemistry (1980-1984). He later served as a Research Assistant Professor at the University of Cincinnati’s Children’s Hospital Research Foundation (1986-1988). His significant career development continued at Wayne State University, where he held various faculty positions from 1988 to 1999, focusing on molecular biology, cancer biology, and toxicology. In 1999, he joined the University of Louisville, where he served as Associate Professor and later Professor in the Department of Pharmacology and Toxicology, achieving tenure in 2004. Dr. States has also held leadership roles, including Vice Chair for Research and Director of the Center for Integrated Environmental Health Sciences at the University of Louisville, with affiliations in the Department of Radiation Oncology and Environmental and Occupational Health. He has also contributed to several national and international scientific advisory boards.

Research Interests:

Dr. States’ research interests span molecular toxicology, environmental health, cancer biology, and arsenic toxicity. His work primarily focuses on the molecular mechanisms of heavy metal exposure, especially arsenic, and its links to carcinogenesis and other health effects. He is deeply involved in studying gene regulation, toxicogenomics, and environmental genotoxicity. His contributions to environmental health sciences extend to leading efforts in environmental genomics and integrative biology, addressing the molecular impacts of environmental toxicants on human health.

Author Metrics:

Dr. States has published extensively in leading journals across the fields of molecular biology, toxicology, and environmental health. He serves on editorial boards, including Toxicology and Applied Pharmacology and Frontiers in Toxicology. His academic contributions have resulted in over 200 peer-reviewed publications, book chapters, and conference presentations, with his work being highly cited in the scientific community. He has also served as an academic editor for PLoS ONE since 2011.

Top Noted Publication:

Arsenic-induced changes in miRNA expression in cancer and other diseases

  • Authors: APF Cardoso, KT Udoh, JC States
  • Journal: Toxicology and Applied Pharmacology
  • Volume: 409
  • Article Number: 115306
  • Citations: 84
  • Year: 2020

Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice

  • Authors: M Tan, RH Schmidt, JI Beier, WH Watson, H Zhong, JC States, GE Arteel
  • Journal: Toxicology and Applied Pharmacology
  • Volume: 257
  • Issue: 3
  • Pages: 356-364
  • Citations: 81
  • Year: 2011

miRNA dysregulation is an emerging modulator of genomic instability

  • Authors: APF Cardoso, M Banerjee, AN Nail, A Lykoudi, JC States
  • Journal: Seminars in Cancer Biology
  • Volume: 76
  • Pages: 120-131
  • Citations: 80
  • Year: 2021

Impact of prenatal arsenic exposure on chronic adult diseases

  • Authors: JL Young, L Cai, JC States
  • Journal: Systems Biology in Reproductive Medicine
  • Volume: 64
  • Issue: 6
  • Pages: 469-483
  • Citations: 69
  • Year: 2018

Phosphorylation and activation of brain tryptophan hydroxylase: identification of serine‐58 as a substrate site for protein kinase A

  • Authors: DM Kuhn, R Arthur Jr, JC States
  • Journal: Journal of Neurochemistry
  • Volume: 68
  • Issue: 5
  • Pages: 2220-2223
  • Citations: 67
  • Year: 1997

Conclusion:

Dr. J. Christopher States is a highly qualified candidate for the Best Researcher Award due to his extensive expertise, significant contributions to toxicology and carcinogenesis, and his recognition as a leader in the field. His impactful research on arsenic and cancer biology has profound implications for public health, while his dedication to mentorship highlights his commitment to advancing science and education. Addressing areas for improvement, such as expanding interdisciplinary collaborations and public engagement, could enhance his already impressive contributions. Overall, Dr. States stands out as an exemplary researcher whose work not only advances scientific understanding but also positively impacts human health.

 

 

Elnaz Elahirad | Oncology Award | Best Researcher Award

Dr. Elnaz Elahirad, Oncology Award, Best Researcher Award

Doctorate at University of Tehran, Iran

Summary:

Dr. Elnaz Elahirad is a dedicated veterinarian with a strong background in veterinary pathology. She completed her Doctor of Veterinary Medicine (DVM) degree at the University of Tehran, Faculty of Veterinary Medicine, where she conducted research on histopathological classification and immunohistochemical evaluation of MMP-9 in canine mammary gland neoplasms. Dr. Elahirad further pursued her postgraduate education as a resident of veterinary pathology at the Department of Pathology, Faculty of Veterinary Medicine, University of Tehran, focusing on histopathological and molecular evaluation of TLR3, 4, 9 in canine mammary gland neoplasms.

Professional Profile:

Scopus Profile

👩‍🎓Education & Qualification:

Doctor of Veterinary Medicine (DVM):

  • Institution: Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  • Duration: September 2007 to completion
  • Research Thesis: Histopathological classification and immunohistochemical evaluation of MMP-9 in canine mammary gland neoplasms

Postgraduate Education (Residency) in Veterinary Pathology:

  • Department: Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  • Duration: September 2013 to completion
  • Research Thesis: Histopathological, histochemical evaluation, and gene expression level assessment of TLR3, TLR4, and TLR9 in canine mammary gland neoplasms

Professional Experience:  

Dr. Elnaz Elahirad has extensive professional experience in the field of veterinary pathology. After completing her Doctor of Veterinary Medicine (DVM) degree, she pursued postgraduate education as a resident in veterinary pathology at the Department of Pathology, Faculty of Veterinary Medicine, University of Tehran, Iran. During this time, she gained practical expertise in histopathological evaluation, immunohistochemistry, and gene expression analysis, particularly focusing on canine mammary gland neoplasms. Dr. Elahirad has also presented her research findings at international conferences and has been recognized for her contributions to the field. Her dedication to advancing veterinary pathology and her commitment to research make her a valuable asset to the veterinary community.

Research Interest:

Dr. Elnaz Elahirad’s research interests primarily revolve around veterinary pathology, with a specific focus on neoplastic diseases in animals, particularly in the context of mammary gland tumors in canines. Her research encompasses histopathological classification, immunohistochemical evaluation, and gene expression analysis to better understand the underlying mechanisms and pathways involved in these diseases. Additionally, Dr. Elahirad is interested in exploring novel diagnostic and therapeutic approaches for the effective management of neoplastic conditions in veterinary medicine.

Publication Top Noted:

TLRs expression in canine mammary gland neoplasms: a pathological and molecular study

  • Authors: Elahirad, E., Gharagozlou, M.J., Khosravi, A., Sasani, F.
  • Journal: Veterinary Immunology and Immunopathology
  • Year: 2023
  • Volume: 261
  • Pages: 110611

Evaluation of cytokeratin 7 expression in different mammary gland neoplasms

  • Authors: Elahirad, E., Sasani, F., Gharagozlou, M.J., Khosravi, A., Khanbarari, F.
  • Journal: Iranian Journal of Veterinary Medicine
  • Year: 2021
  • Volume: 15
  • Issue: 1
  • Pages: 56–67

The biomedical potential of cellulose acetate/polyurethane nanofibrous mats containing reduced graphene oxide/silver nanocomposites and curcumin: Antimicrobial performance and cutaneous wound healing

  • Authors: Esmaeili, E., Eslami-Arshaghi, T., Hosseinzadeh, S., Hatamie, S., Soleimani, M.
  • Journal: International Journal of Biological Macromolecules
  • Year: 2020
  • Volume: 152
  • Pages: 418–427

Improved cellular response on functionalized polypyrrole interfaces

  • Authors: Naghavi Alhosseini, S., Moztarzadeh, F., Karkhaneh, A., Elahirad, E., Mozafari, M.
  • Journal: Journal of Cellular Physiology
  • Year: 2019
  • Volume: 234
  • Issue: 9
  • Pages: 15279–15287